Coronary events with lipid-lowering therapy: The AFCAPS/TexCAPS trial

被引：0
|
作者：
McDiarmid, TD [1 ]
Hensel, WA [1 ]
机构：
[1] Moses Cone Hlth Syst, Greensboro, NC 27401 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1999年 / 281卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：416 / 416
页数：1
相关论文
共 50 条
  • [31] 25 years of lipid-lowering therapy: secular trends in therapy of coronary patients
    Ratz, Magdalena
    Vogel, Johannes B.
    Kuehrer, Heike
    Saely, Christoph H.
    Muendlein, Axel
    Vonbank, Alexander
    Mader, Arthur
    Fraunberger, Peter
    Leiherer, Andreas
    Drexel, Heinz
    WIENER KLINISCHE WOCHENSCHRIFT, 2024,
  • [32] Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
    Gotto, AM
    Whitney, E
    Stein, EA
    Shapiro, DR
    Clearfield, M
    Weis, S
    Jou, JY
    Langendörfer, A
    Beere, A
    Watson, DJ
    Downs, JR
    de Cani, JS
    CIRCULATION, 2000, 101 (05) : 477 - 484
  • [33] Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis - A randomized controlled trial
    Nissen, SE
    Tuzcu, EM
    Schoenhagen, P
    Brown, BG
    Ganz, P
    Vogel, RA
    Crowe, T
    Howard, G
    Cooper, CJ
    Brodie, B
    Grines, CL
    DeMaria, AN
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (09): : 1071 - 1080
  • [34] Combination Lipid-Lowering Therapy in Patients Undergoing Percutaneous Coronary Intervention
    Lee, Seung-Jun
    Joo, Jae Hong
    Park, Sohee
    Kim, Choongki
    Choi, Dong-Woo
    Hong, Sung-Jin
    Ahn, Chul-Min
    Kim, Jung-Sun
    Kim, Byeong-Keuk
    Ko, Young-Guk
    Choi, Donghoon
    Jang, Yangsoo
    Nam, Chung-Mo
    Hong, Myeong-Ki
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (05) : 401 - 410
  • [35] Trials of lipid-lowering therapy in primary prevention of coronary heart disease
    Jones, PH
    CURRENT OPINION IN LIPIDOLOGY, 1995, 6 (06) : 365 - 368
  • [36] Concomitant Coronary Atheroma Regression and Stabilization in Response to Lipid-Lowering Therapy
    Biccire, Flavio G.
    Haner, Jonas
    Losdat, Sylvain
    Ueki, Yasushi
    Shibutani, Hiroki
    Otsuka, Tatsuhiko
    Kakizaki, Ryota
    Hofbauer, Thomas M.
    van Geuns, Robert-Jan
    Stortecky, Stefan
    Siontis, George C. M.
    Bar, Sarah
    Lonborg, Jacob
    Heg, Dik
    Kaiser, Christoph
    Spirk, David
    Daemen, Joost
    Iglesias, Juan F.
    Windecker, Stephan
    Engstrom, Thomas
    Lang, Irene
    Koskinas, Konstantinos C.
    Raber, Lorenz
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (18) : 1737 - 1747
  • [37] The Lipoprotein and Coronary Atherosclerosis Study documents benefits of a lipid-lowering therapy
    Griebenow, R
    PERFUSION, 1997, 10 (12): : 462 - 462
  • [38] Reinforcing adherence to lipid-lowering therapy after an acute coronary syndrome: A pragmatic randomized controlled trial
    Zafeiropoulos, Stefanos
    Farmakis, Ioannis
    Kartas, Anastasios
    Arvanitaki, Alexandra
    Pagiantza, Areti
    Boulmpou, Aristi
    Tampaki, Athina
    Kosmidis, Diamantis
    Nevras, Vassileios
    Markidis, Eleftherios
    Papadimitriou, Ioannis
    Vlachou, Anastasia
    Arvanitakis, Konstantinos
    Miyara, Santiago J.
    Ziakas, Antonios
    Molmenti, Ernesto P.
    Kassimis, George
    Zanos, Stavros
    Karvounis, Haralambos
    Giannakoulas, George
    ATHEROSCLEROSIS, 2021, 323 : 37 - 43
  • [39] Trials of lipid-lowering therapy in secondary prevention of coronary heart disease
    Olsson, AG
    Pedersen, T
    Bergdahl, B
    CURRENT OPINION IN LIPIDOLOGY, 1995, 6 (06) : 369 - 373
  • [40] Frequency of lipid-lowering therapy after a coronary event in Helsinki, Finland
    Strandberg, TE
    Vanhanen, H
    Tikkanen, MJ
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (01): : 95 - +
12345